Enliven Therapeutics Inc (ELVN)

Change in Working Capital

-$605.00K

Quarterly · Period ending: · USD

ELVN logo

ELVN Change in Working Capital

Latest reported-$605.00K
ELVN Quarterly Change in Working Capital ($1.69M → -$605.00K)
High-resolution chart · PNG

ELVN change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-605,000
-3,434,000
1,219,000
-157,000
313,000
-2,496,000
-510,000
4,988,000
-4,384,000
-4,635,000
5,464,000
3,152,000
1,234,000
-8,449,000
606,000
1,205,000
1,012,000
-2,385,000
779,000
1,702,000
1,823,000
-3,790,000
2,368,000
1,459,000
386,000
-2,701,000
-1,101,000
30,000
52,000
1,692,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.